0000899243-19-022005.txt : 20190819 0000899243-19-022005.hdr.sgml : 20190819 20190819083530 ACCESSION NUMBER: 0000899243-19-022005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190816 FILED AS OF DATE: 20190819 DATE AS OF CHANGE: 20190819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAHAFFY PATRICK J CENTRAL INDEX KEY: 0001266569 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35347 FILM NUMBER: 191034984 MAIL ADDRESS: STREET 1: C/O PHARMION CORP STREET 2: 2525 28TH ST CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clovis Oncology, Inc. CENTRAL INDEX KEY: 0001466301 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900475355 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (303) 625-5000 MAIL ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-08-16 0 0001466301 Clovis Oncology, Inc. CLVS 0001266569 MAHAFFY PATRICK J C/O CLOVIS ONCOLOGY, INC. 5500 FLATIRON PARKWAY, SUITE 100 BOULDER CO 80301 1 1 0 0 President and CEO Common Stock 2019-08-16 4 P 0 400 5.56 A 919187 D Common Stock 2019-08-16 4 P 0 400 5.58 A 919587 D Common Stock 2019-08-16 4 P 0 3706 5.57 A 923293 D Common Stock 2019-08-16 4 P 0 2100 5.61 A 925393 D Common Stock 2019-08-16 4 P 0 6400 5.61 A 931793 D Common Stock 2019-08-16 4 P 0 11314 5.58 A 943107 D Common Stock 2019-08-16 4 P 0 3700 5.59 A 946807 D Common Stock 2019-08-16 4 P 0 11053 5.59 A 957860 D Common Stock 2019-08-16 4 P 0 5100 5.60 A 962960 D Common Stock 2019-08-16 4 P 0 5827 5.60 A 968787 D Common Stock 1000 I By son Common Stock 1000 I By daughter The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. /s/ Patrick Mahaffy 2019-08-16